- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有70家主力机构披露2024-12-31报告期持股数据，持仓量总计1582.76万股，占流通A股28.38%
- 波段诊断：
-
技术面诊股
诊断结果：3.9技术面打败了74%的股票
技术面评分前10的股票
近期的平均成本为33.05元。
平均成本
近期的平均成本为33.05元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"33.05","date":1743584736,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2025.04.03","stock":"-0.88","trade":"0.45","ind":"-0.24"},{"date":"2025.04.02","stock":"-0.48","trade":"0.10","ind":"0.05"},{"date":"2025.04.01","stock":"6.25","trade":"4.61","ind":"0.38"},{"date":"2025.03.31","stock":"-2.16","trade":"-1.52","ind":"-0.46"},{"date":"2025.03.28","stock":"5.21","trade":"-0.35","ind":"-0.67"},{"date":"2025.03.27","stock":"5.20","trade":"2.25","ind":"0.15"},{"date":"2025.03.26","stock":"0.03","trade":"0.93","ind":"-0.04"},{"date":"2025.03.25","stock":"-0.62","trade":"0.61","ind":"-0.00"},{"date":"2025.03.24","stock":"-4.07","trade":"-1.49","ind":"0.15"},{"date":"2025.03.21","stock":"-2.95","trade":"-1.36","ind":"-1.29"},{"date":"2025.03.20","stock":"-2.75","trade":"-0.68","ind":"-0.51"},{"date":"2025.03.19","stock":"1.01","trade":"-0.21","ind":"-0.10"},{"date":"2025.03.18","stock":"0.92","trade":"0.53","ind":"0.11"},{"date":"2025.03.17","stock":"0.42","trade":"0.25","ind":"0.19"},{"date":"2025.03.14","stock":"0.61","trade":"2.51","ind":"1.81"},{"date":"2025.03.13","stock":"-3.21","trade":"-0.67","ind":"-0.39"},{"date":"2025.03.12","stock":"-5.03","trade":"-0.35","ind":"-0.23"},{"date":"2025.03.11","stock":"-0.53","trade":"0.05","ind":"0.41"},{"date":"2025.03.10","stock":"-0.23","trade":"1.54","ind":"-0.19"},{"date":"2025.03.07","stock":"-2.15","trade":"-0.69","ind":"-0.25"},{"date":"2025.03.06","stock":"3.32","trade":"1.14","ind":"1.17"}]
首药控股,上证指数,化学制药指数
压力支撑
该股压力位为32.97元，支撑位为32.02元。
[{"text":"\u538b\u529b\u4f4d","value":"32.97","date":1743609600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"32.02","date":1743609600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了45%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：04月03日 20:31
| 机构今日流向(万元) | -388.73 | 机构5日流向(万元) | 1481.80 |
| 机构10日流向(万元) | 2360.56 | 机构20日流向(万元) | -1924.35 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少1848.23万股，其中基金净减仓7家，主力净减仓43家，请投资者中长期谨慎为宜。
截止2024-12-31，共70家主力机构（基金70家），持仓量总计1582.76万股，占流通A股28.38%
其中，基金持仓与2024-06-30相比：
增仓：10家 ，增持 125.54万股
减仓：17家 ，减持 172.95万股
新出现在主力名单中：32家 ，持有364.56万股
从主力名单中消失：75家 ，原持有2165.38万股
其中，基金持仓与2024-06-30相比：
增仓：10家 ，增持 125.54万股
减仓：17家 ，减持 172.95万股
新出现在主力名单中：32家 ，持有364.56万股
从主力名单中消失：75家 ，原持有2165.38万股
消息面诊股
诊断结果：5.5消息面打败了69%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 首药控股：4月2日获融资买入295.09万元
2025-04-03 - 首药控股：4月1日获融资买入692.32万元，占当
2025-04-02 - 鹏华医药科技股票A重仓股首药控股-U涨6.25%
2025-04-01 - 首药控股：3月31日获融资买入329.31万元
2025-04-01 - 出海按下加速键！创新药有望成为2025年最耀眼板块
2025-03-31 - 首药控股：3月28日获融资买入829.62万元，占
2025-03-29 - 今日医药板块大涨，百花医药、润都股份等涨停
2025-03-28 - 鹏华医药科技股票A重仓股首药控股-U涨5.21%
2025-03-28 - 冠昊生物等创新药股：3 月 28 日大幅拉升
2025-03-28 - 创新药概念股大涨 冠昊生物直线拉升录得20cm涨停
2025-03-28
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2024-12-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-26 |
| 一般消息 | 高管变动 | 根据中国工程院院士兼职管理的相关规... | 2024-05-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：4.3行业面打败了64%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑赢大盘。
行业走势
近10日来该行业走势不明显，明显跑赢大盘。
[{"date":"2025.04.03","price":"-0.24","value":"0.45"},{"date":"2025.04.02","price":"0.05","value":"0.10"},{"date":"2025.04.01","price":"0.38","value":"4.61"},{"date":"2025.03.31","price":"-0.46","value":"-1.52"},{"date":"2025.03.28","price":"-0.67","value":"-0.35"},{"date":"2025.03.27","price":"0.15","value":"2.25"},{"date":"2025.03.26","price":"-0.04","value":"0.93"},{"date":"2025.03.25","price":"-0.00","value":"0.61"},{"date":"2025.03.24","price":"0.15","value":"-1.49"},{"date":"2025.03.21","price":"-1.29","value":"-1.36"},{"date":"2025.03.20","price":"-0.51","value":"-0.68"},{"date":"2025.03.19","price":"-0.10","value":"-0.21"},{"date":"2025.03.18","price":"0.11","value":"0.53"},{"date":"2025.03.17","price":"0.19","value":"0.25"},{"date":"2025.03.14","price":"1.81","value":"2.51"},{"date":"2025.03.13","price":"-0.39","value":"-0.67"},{"date":"2025.03.12","price":"-0.23","value":"-0.35"},{"date":"2025.03.11","price":"0.41","value":"0.05"},{"date":"2025.03.10","price":"-0.19","value":"1.54"},{"date":"2025.03.07","price":"-0.25","value":"-0.69"},{"date":"2025.03.06","price":"1.17","value":"1.14"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 能特科技 | 139.32% | -9.09% | 5.4分 |
| 2 | 润都股份 | 98.98% | 39.71% | 5.0分 |
| 3 | 多瑞医药 | 65.50% | 50.00% | 4.8分 |
| 4 | 金城医药 | 54.54% | 4.96% | 5.0分 |
| 5 | 一品红 | 43.28% | 29.51% | 5.7分 |
| 6 | 哈三联 | 35.25% | 30.63% | 4.8分 |
| 8 | 翰宇药业 | 26.11% | 11.91% | 5.9分 |
| 10 | 海思科 | 24.80% | 10.82% | 6.4分 |
| 12 | 广济药业 | 21.70% | 4.95% | 5.0分 |
| 14 | 新天地 | 19.99% | 7.45% | 4.4分 |
| 16 | 苑东生物 | 18.26% | 12.40% | 5.9分 |
| 18 | 百利天恒 | 14.93% | 11.28% | 6.3分 |
| 20 | 海翔药业 | 12.80% | -0.38% | 4.9分 |
| 22 | 华特达因 | 12.63% | -0.03% | 4.7分 |
| 24 | 信立泰 | 12.12% | 5.48% | 5.8分 |
| 26 | 美诺华 | 10.92% | 1.36% | 4.5分 |
| 28 | 国邦医药 | 10.51% | 3.49% | 5.4分 |
| 30 | 恒瑞医药 | 9.72% | 5.48% | 6.6分 |
| 32 | 天宇股份 | 9.40% | -2.55% | 5.3分 |
| 34 | 海正药业 | 9.15% | 5.20% | 5.7分 |
| 36 | 吉贝尔 | 8.83% | 5.46% | 5.7分 |
| 38 | 溢多利 | 8.62% | 5.45% | 5.0分 |
| 40 | 益方生物 | 8.47% | 3.27% | 5.4分 |
| 42 | 本立科技 | 8.20% | 1.61% | 5.0分 |
| 44 | 博瑞医药 | 8.14% | 3.83% | 4.7分 |
| 46 | 百济神州 | 7.87% | 8.25% | 5.9分 |
| 48 | 华邦健康 | 7.77% | 2.46% | 5.4分 |
| 50 | 华海药业 | 7.62% | -0.12% | 5.2分 |
| 52 | 昂利康 | 7.09% | 3.20% | 4.8分 |
| 54 | 海创药业 | 6.92% | 25.78% | 5.7分 |
| 56 | 富士莱 | 6.81% | 5.54% | 3.9分 |
| 58 | 亚太药业 | 6.55% | 3.77% | 4.6分 |
| 60 | 立方制药 | 6.42% | 0.62% | 5.9分 |
| 62 | 山河药辅 | 5.58% | 1.82% | 4.7分 |
| 64 | 仙琚制药 | 5.39% | -1.45% | 4.8分 |
| 66 | 福元医药 | 5.30% | -0.06% | 5.1分 |
| 68 | 华仁药业 | 4.84% | 0.93% | 4.9分 |
| 70 | 诺泰生物 | 4.82% | -7.29% | 5.2分 |
| 72 | *ST景峰 | 4.67% | -7.19% | 4.3分 |
| 74 | 西点药业 | 4.55% | 3.82% | 5.2分 |
| 76 | 上海谊众 | 4.38% | 7.43% | 4.8分 |
| 78 | 康芝药业 | 4.03% | -0.96% | 4.1分 |
| 80 | 盟科药业 | 3.93% | 3.75% | 4.9分 |
| 82 | 健康元 | 3.61% | 1.90% | 5.1分 |
| 84 | 北大医药 | 3.40% | 0.83% | 4.8分 |
| 86 | 拓新药业 | 3.33% | 6.17% | 4.4分 |
| 88 | 新华制药 | 3.03% | 0.79% | 5.0分 |
| 90 | 华润双鹤 | 3.00% | 2.57% | 5.6分 |
| 92 | 悦康药业 | 2.56% | 1.99% | 4.6分 |
| 94 | 赛分科技 | 2.39% | 1.21% | 5.0分 |
| 96 | 力生制药 | 2.07% | 0.70% | 4.0分 |
| 98 | 复星医药 | 2.00% | 2.08% | 5.3分 |
| 100 | 键凯科技 | 1.95% | 8.56% | 4.0分 |
| 102 | 贝达药业 | 1.75% | 2.91% | 5.8分 |
| 104 | 健友股份 | 0.74% | -4.53% | 4.9分 |
| 106 | 中关村 | 0.61% | -1.00% | 4.7分 |
| 108 | 复旦张江 | 0.36% | 1.10% | 4.7分 |
| 110 | 南新制药 | 0.00% | 1.95% | 4.2分 |
| 112 | 新和成 | -0.14% | -4.03% | 5.1分 |
| 114 | 华北制药 | -0.32% | -4.41% | 4.8分 |
| 116 | 双鹭药业 | -0.43% | -0.58% | 3.9分 |
| 118 | 汇宇制药 | -0.72% | 1.36% | 5.5分 |
| 120 | ST三圣 | -0.80% | -1.84% | 4.3分 |
| 122 | - | -1.32% | 0.27% | 分 |
| 124 | *ST普利 | -1.58% | -8.12% | 3.4分 |
| 126 | 威尔药业 | -1.88% | -3.25% | 5.3分 |
| 128 | 华纳药厂 | -2.20% | 0.34% | 5.5分 |
| 130 | 向日葵 | -2.56% | 0.00% | 3.3分 |
| 132 | 尔康制药 | -3.62% | -0.75% | 3.9分 |
| 134 | 国药现代 | -4.35% | -6.43% | 4.7分 |
| 136 | 赛托生物 | -5.17% | -0.88% | 4.4分 |
| 138 | 首药控股 | -6.09% | 7.88% | 4.2分 |
| 140 | 花园生物 | -6.64% | -2.00% | 4.4分 |
| 142 | 常山药业 | -7.61% | -3.41% | 4.3分 |
| 144 | 复旦复华 | -8.72% | -10.66% | 3.6分 |
| 146 | 海南海药 | -11.78% | -2.77% | 3.8分 |
| 148 | 江苏吴中 | -16.17% | -3.09% | 4.2分 |
| 150 | 赛隆药业 | -24.23% | -2.59% | 4.1分 |
| 152 | 仟源医药 | - | 8.01% | 5.2分 |
| 154 | 丰原药业 | - | 3.72% | 5.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"-17.00","vol":"4.52"},{"date":"2024-06-30","value":"-10.61","vol":"3.49"},{"date":"2024-03-31","value":"-5.36","vol":"2.32"},{"date":"2023-12-31","value":"-16.66","vol":"-2.41"},{"date":"2023-09-30","value":"-11.95","vol":"2.53"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-17.00 | -10.61 | -5.36 | -16.66 | -11.95 |
| 行业(%) | 4.52 | 3.49 | 2.32 | -2.41 | 2.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"50.55"},{"date":"2024-06-30","value":"","vol":"50.91"},{"date":"2024-03-31","value":"","vol":"50.62"},{"date":"2023-12-31","value":"97.87","vol":"51.63"},{"date":"2023-09-30","value":"","vol":"51.68"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
- | - | - | 97.87 | - |
| 行业(%) | 50.55 | 50.91 | 50.62 | 51.63 | 51.68 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 133/228 ， 104/228。
[{"date":"2024-09-30","value":"-24.00","vol":"44.93"},{"date":"2024-06-30","value":"-24.00","vol":"700.68"},{"date":"2024-03-31","value":"","vol":"749.72"},{"date":"2023-12-31","value":"186.18","vol":"353.65"},{"date":"2023-09-30","value":"180.08","vol":"122.98"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-24.00 | -24.00 | - | 186.18 | 180.08 |
| 行业(%) | 44.93 | 700.68 | 749.72 | 353.65 | 122.98 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-17.59","vol":"-16.98"},{"date":"2024-06-30","value":"-10.46","vol":"7.37"},{"date":"2024-03-31","value":"-13.21","vol":"18.10"},{"date":"2023-12-31","value":"-6.76","vol":"-47.20"},{"date":"2023-09-30","value":"-14.17","vol":"13.96"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-17.59 | -10.46 | -13.21 | -6.76 | -14.17 |
| 行业(%) | -16.98 | 7.37 | 18.10 | -47.20 | 13.96 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"0.00","vol":"0.33"},{"date":"2024-06-30","value":"0.00","vol":"0.23"},{"date":"2024-03-31","value":"","vol":"0.12"},{"date":"2023-12-31","value":"0.00","vol":"0.44"},{"date":"2023-09-30","value":"0.00","vol":"0.33"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.00 | 0.00 | - | 0.00 | 0.00 |
| 行业(次) | 0.33 | 0.23 | 0.12 | 0.44 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"2.16"},{"date":"2024-06-30","value":"","vol":"1.50"},{"date":"2024-03-31","value":"","vol":"0.74"},{"date":"2023-12-31","value":"0.09","vol":"2.78"},{"date":"2023-09-30","value":"","vol":"2.03"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
- | - | - | 0.09 | - |
| 行业(次) | 2.16 | 1.50 | 0.74 | 2.78 | 2.03 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"","vol":"-10.05"},{"date":"2024-06-30","value":"-1365.52","vol":"-254.27"},{"date":"2024-03-31","value":"","vol":"-4.44"},{"date":"2023-12-31","value":"-19237.61","vol":"-123.06"},{"date":"2023-09-30","value":"","vol":"-16.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | - | -1365.52 | - | -19237.61 | - |
| 行业 | -10.05 | -254.27 | -4.44 | -123.06 | -16.07 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.94","vol":"2.18"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.51","vol":"2.34"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.94 | - | 0.51 | - |
| 行业 | 0.00 | 2.18 | 0.00 | 2.34 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 132/228 ， 119/228。
[{"date":"2024-09-30","value":"7.08","vol":"3.65"},{"date":"2024-06-30","value":"7.48","vol":"3.58"},{"date":"2024-03-31","value":"8.50","vol":"3.74"},{"date":"2023-12-31","value":"10.90","vol":"3.71"},{"date":"2023-09-30","value":"11.32","vol":"4.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
7.08 | 7.48 | 8.50 | 10.90 | 11.32 |
| 行业 | 3.65 | 3.58 | 3.74 | 3.71 | 4.07 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"3.97","vol":"2.91"},{"date":"2024-06-30","value":"5.01","vol":"2.88"},{"date":"2024-03-31","value":"5.50","vol":"3.08"},{"date":"2023-12-31","value":"7.00","vol":"3.01"},{"date":"2023-09-30","value":"7.97","vol":"3.33"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.97 | 5.01 | 5.50 | 7.00 | 7.97 |
| 行业 | 2.91 | 2.88 | 3.08 | 3.01 | 3.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 122/228 ， 125/228。
[{"date":"2024-09-30","value":"12.57","vol":"33.03"},{"date":"2024-06-30","value":"10.70","vol":"33.21"},{"date":"2024-03-31","value":"9.22","vol":"33.13"},{"date":"2023-12-31","value":"8.20","vol":"33.46"},{"date":"2023-09-30","value":"7.39","vol":"32.26"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.57 | 10.70 | 9.22 | 8.20 | 7.39 |
| 行业(%) | 33.03 | 33.21 | 33.13 | 33.46 | 32.26 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.14","vol":"0.73"},{"date":"2024-06-30","value":"0.12","vol":"0.71"},{"date":"2024-03-31","value":"0.10","vol":"0.70"},{"date":"2023-12-31","value":"0.09","vol":"0.75"},{"date":"2023-09-30","value":"0.08","vol":"0.71"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.14 | 0.12 | 0.10 | 0.09 | 0.08 |
| 行业(%) | 0.73 | 0.71 | 0.70 | 0.75 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2024年的收益，请投资者后续关注。
[{"date":"2020","yellowRectValue":"-3.30","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"-1.46","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.74","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.86","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]